Ibriturnomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation in patients with chemo-refractory non-Hodgkin's lymphoma.

被引：0
作者：
Shimoni, A [1 ]
Zwas, T [1 ]
Oksman, Y [1 ]
Hardan, I [1 ]
Shem-Tov, N [1 ]
Yerushalmi, R [1 ]
Avigdor, A [1 ]
Ben-Bassat, I [1 ]
Nagler, A [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1131
引用
收藏
页码：329A / 329A
页数：1
相关论文
共 50 条
  • [21] Ibritumomab tiuxetan (Zevalin) followed by high-dose chemotherapy and autologous stem-cell transplantation results in improved survival of patients with chemo-refractory non-Hodgkin's lymphoma expected to have poor outcome with standard pre-transplant conditioning.
    Shimoni, Avichai
    Zwass, Tsila
    Oksman, Yaacov
    Hardan, Izhar
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Avigdor, Abraham
    Ben-Bassat, Isaac
    Nagler, Arnon
    [J]. BLOOD, 2006, 108 (11) : 869A - 869A
  • [22] Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
    Armand, Philippe
    Kim, Haesook T.
    Ho, Vincent T.
    Cutler, Corey S.
    Koreth, John
    Antin, Joseph H.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Fisher, David C.
    Brown, Jennifer R.
    Canellos, George P.
    Freedman, Arnold S.
    Soiffer, Rohert J.
    Alyea, Edwin P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) : 418 - 425
  • [23] Conditioning Regimen Comparison for Allogeneic Stem Cell Transplantation in non-hodgkin Lymphoma
    Peterson, Kristen
    Lin, Andrew
    Ruiz, Josel
    Zheng, Junting
    Devlin, Sean
    Shah, Gunjan
    Scordo, Michael
    Sauter, Craig
    Perales, Miguel
    Giralt, Sergio
    Buie, Larry
    Dahi, Parastoo
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 299 - 300
  • [24] Autologous stem-cell transplantation in Hodgkin's and non-Hodgkin's lymphoma
    Greinix, HT
    [J]. ACTA MEDICA AUSTRIACA, 2000, 27 : 25 - 29
  • [25] Autologous stem cell transplantation in patients with refractory and/or relapsed low grade non-Hodgkin's lymphoma.
    Mallidi, PV
    Qazilbash, MH
    Devetten, MP
    Beall, CL
    Weisenborn, R
    Bunner, P
    Ericson, SG
    [J]. BLOOD, 2001, 98 (11) : 394B - 394B
  • [26] Reduced-intensity rituximab-BEAM-CAMPATH allogeneic transplantation for indolent non-Hodgkin's lymphoma.
    Ho, AYL
    Devereux, S
    Mufti, GL
    Pagliuca, A
    [J]. BLOOD, 2001, 98 (11) : 188A - 188A
  • [27] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [28] Allogeneic peripheral blood stem cell transplantation after reduced-intensity conditioning in refractory or relapsed Hodgkin lymphoma
    Alvarez, I
    Sureda, A
    Caballero, D
    Urbano, A
    Ribera, J
    Canales, M
    Hernández-Boluda, J
    Arranz, R
    Bernal, T
    de la Serna, J
    Diez, JL
    Moraleda, J
    Rubio-Félix, D
    Sierra, J
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S13 - S14
  • [29] Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era
    Anderlini, Paolo
    Saliba, Rima
    Ledesma, Celina
    Chancoco, Christina M.
    Alexander, Tamera R.
    Alousi, Amin M.
    Hosing, Chitra
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Oki, Yasuhiro
    Romaguera, Jorge E.
    Neelapu, Sattva S.
    Younes, Anas
    Champlin, Richard E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S72 - S72
  • [30] Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced low/intermediate grade non-Hodgkin lymphoma
    Bethge, W. A.
    Bornhaeuser, M.
    Lange, T.
    Vucinic, V.
    Uharek, L.
    Stelljes, M.
    Stadler, M.
    Bunjes, D.
    Faul, C.
    Kanz, L.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S90 - S90
12345